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electron-beam dual-source computed tomography and Agatston scores.Results After adjustment for demographicandclinical variablesassociatedwithCVDaswell as for inﬂammatory factors,we found
a robust association between cortisol response and detectable hs-cTnT (odds ratio [OR]: 3.98; 95% conﬁdence interval
[CI]: 1.60 to 9.92; p¼ 0.003). The association remainedwhen we restricted the analysis to participants without coronary
calciﬁcation (n¼ 222; OR: 4.77; 95%CI: 1.22 to 18.72; p¼ 0.025) or whenwe further adjusted for coronary calciﬁcation
in participants with positive Agatston scores (n¼ 286; OR: 7.39; 95% CI: 2.22 to 26.24; p ¼ 0.001).Conclusions We found that heightened cortisol response to mental stress was associated with detectable plasma levels of cTnT
using high-sensitivity assays in healthy participants, independently of coronary atherosclerosis. Further research is
needed to understand the role of psychosocial stress in the pathophysiology of cardiac cell damage. (J Am Coll
Cardiol 2013;62:1694–701) ª 2013 by the American College of Cardiology FoundationSee page 1702Mental stress is becoming increasingly recognized as a risk
factor and trigger for cardiovascular disease (CVD) events (1–
3). Stress can be studied in several ways, including epidemi-
ological studies, laboratory-based psychophysiological testing,
and animal research. Psychophysiological testing allows
mechanisms to be studied by measuring biological responses
to standardized behavioral challenge. Stress markers relevant
to CVD include proinﬂammatory factors, cortisol level, heart
rate variability, and hemostatic processes (4,5). Mental stress
initiates the release of cortisol by activating corticotropin-
releasing factor and arginine vasopressin neurons in the par-
aventricular nucleus of the hypothalamus (6). This leads to the
release of adrenocorticotropic hormone from the pituitaryology and Public Health, University College
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; accepted May 7, 2013.gland, which triggers release of glucocorticoids from the
adrenal glands. Cortisol has attracted relatively little attention
as a mechanism linking stress and CVD. However, several
population studies have demonstrated associations between
diurnal cortisol patterns and subclinical atherosclerosis (7,8).Additionally, aﬂatter slope in thedecline of cortisol levels across
the day (thought to be a marker of chronic stress) is associated
with an increased risk ofCVDmortality inBritish civil servants
(9); 24-h urinary cortisol level was associated with CVD
death in the InCHIANTI (Invecchiare [Aging] in Chianti
[region in Italy]) prospective cohort study of older people (10);
serum cortisol levels were found to be a cardiac event risk
predictor in patients with chronic heart failure; and cardiac
event prediction based on cortisol levels was inﬂuenced by
oxidative stress (11). Recent data from our laboratory have
shown that heightened increases in salivary cortisol levels
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1695following standardized mental stress tests in healthy older
individuals were associated with greater coronary artery calci-
ﬁcation (CAC) andwithCACprogressionover 3 years (12,13).
Cardiac troponin T (cTnT) is a plasma protein routinely
used for the diagnosis of acute myocardial infarction (AMI)
(14,15). In clinical settings cTnT is measured using standard
assays that have a detection limit of 10 ng/l (16) and a diag-
nostic threshold of 35 ng/l (14,15). However, high-sensitivity
assays (hs-cTnT) have now been developed with a lower
detection limit of 3 ng/l (17–19). In healthy people not
fulﬁlling any diagnostic criteria for AMI, greater hs-cTnT
level is associated with a greater incidence of structural and
functional heart disease, cardiovascular mortality, and all-
cause mortality (20,21). Among patients undergoing
noncardiac surgery, the post-operative increase in hs-cTnT
plasma concentration was associated with increased 30-day
mortality (22). In a study of community-derived peri-
menopausal women, hs-cTnT level was associated with
long-term mortality, independently of amino-terminal
pro–B-type natriuretic peptide and other risk factors (23).
Cortisol is associated with coronary atherosclerosis, al-
though whether this hormone plays a role in structural and
functional cardiac disease remains unclear. The aim of our
study was therefore to provide further insight into the role of
cortisol in CVD by examining the association between
cortisol responses to mental stress and hs-cTnT concentra-
tions in healthy older individuals without a history of CVD,
taking into account underlying coronary atherosclerosis. We
hypothesized that high cortisol responders are individuals
who are hyperreactive to mental stress. If these responses are
elicited on a regular basis over many years, they might lead to
chronic elevation in hs-cTnT concentration.Methods
Study design. Our study involved participants drawn from
the Whitehall II epidemiological cohort (24) for psycho-
physiological testing between 2006 and 2008. The criteria for
entry into the study included no history or objective signs of
clinical or subclinical CVD and no previous diagnosis or
treatment for hypertension, inﬂammatory diseases, allergies,
or kidney disease. CVD was deﬁned as prior MI, stable or
unstable angina, revascularization procedure, heart failure,
transient ischemic attack, stroke, or electrocardiographic
abnormalities (resting 12-lead electrocardiograms were taken).
This information was conﬁrmed by a telephone interview
and veriﬁed from clinical data collected from the previous 7
phases of the Whitehall II study. Volunteers were of white
European origin, aged 53 to 76 years; 56.5% were in full-time
employment. Selection was stratiﬁed by grade of employment
(current or most recent) to include higher and lower socio-
economic status participants. From the initially invited par-
ticipants (N¼ 1,169), 27.6%were not eligible (mainly because
of prescribed medications) and 25.9% declined to take part.
Participants were prohibited from using any antihistamine or
anti-inﬂammatory medication for 7 days before testing andwere rescheduled if they reported
colds or other infections on the
day of testing. Participants gave
full informed consent to partici-
pate in the study, and ethical
approval was obtained from the
University College London Hos-
pitals Committee on the Ethics of
Human Research.
Data collection. PSYCHOPHYSIO-
LOGICALTESTING. Wecarried out
psychophysiological stress testing
in either the morning or afternoon
in a light temperature-controlled
laboratory. This procedure was
based on a protocol previously used
in this laboratory (25). Partici-
pants were instructed to refrain from drinking caffeinated
beverages and smoking for at least 2 h before the study
and not to have performed vigorous physical activity or
consumed alcohol the previous evening. After a 30-min rest
period, baseline blood pressure (using an automated UA-
779 digital monitor [A&D Instruments Ltd., Oxford,
United Kingdom]) and a saliva sample were taken. Two
behavioral tasks, designed to induce mental stress, were then
administered in random order. The tasks were a com-
puterized version of the Stroop task and mirror tracing, both
of which have been used extensively in psychophysiological
research (26). The tasks each lasted for 5 min. Saliva samples
were collected immediately before and after the tasks for the
assessment of salivary cortisol. The samples were collected
using Salivettes (Sarsted, Leicester, United Kingdom),
which were stored at 30C until analysis. Levels of cortisol
were assessed using a time-resolved immunoassay with
ﬂuorescence detection at the University of Dresden (Dres-
den, Germany). The intra-assay and interassay coefﬁcients
of variation (CVs) were less than 8%.
CARDIAC TROPONIN T. Nonfasting blood samples were
collected in EDTA tubes and centrifuged immediately at
2,500 rpm for 10 min at room temperature. Plasma was
removed from the tube and aliquoted into 0.5-ml portions
and stored at 80C until analysis. We measured cTnT
concentrations 75 min after the end of the mental stress test
using a highly sensitive assay on an automated platform
(Elecsys-2010 Troponin T hs STAT, Roche Diagnostics,
Haywards Heath, United Kingdom), with a lower detection
limit of 3 ng/l and a reported 99th percentile value in
apparently healthy individuals of 13.5 ng/l, at which the CV
is 9%, conﬁrmed by in-house studies (17–19).
COVARIATES. We assayed baseline plasma interleukin (IL)-6
using a Quantikine high-sensitivity 2-site enzyme-linked
immunosorbent assay (ELISA) from R&D Systems (Ox-
ford, United Kingdom). The sensitivity of the assay ranged
from 0.016 to 0.110 pg/ml, with intra-assay and interassay
CVs of 7.3% and 7.7%, respectively. Baseline C-reactive
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ELISA (R&D Systems).
CAC was assessed with electron-beam computed
tomography (Imatron C-150, General Electric, San Fran-
cisco, California) as previously described (27). In brief, 40
contiguous 3-mm slices were obtained during a single
breath-hold starting at the carina and proceeding to the level
of the diaphragm. Scan time was 100 ms/slice, synchronized
to 40% of the R-R interval. Agatston and volumetric calcium
scores were calculated to quantify the extent of CAC by
a single experienced investigator blinded to the psycho-
physiological and clinical data on an Aquarius workstation
(TeraRecon Inc., San Mateo, California). Because calciﬁed
volume was highly correlated with Agatston score (Spearman
rho 0.99), we present data for Agatston score only.
Participants reported current smoking levels, weekly
alcohol intake (units per week), employment grade (as a marker
of social position), and hours of moderate or vigorous
physical activity per week. We measured height and weight
in light clothing for calculation of body mass index (BMI).
Fasting blood samples were taken during a separate clinical
assessment. Total and high-density lipoprotein (HDL)
cholesterol and triglycerides were measured within 72 h in
serum stored at 4C using enzymatic colorimetric methods
(28). Low-density lipoprotein (LDL) cholesterol level was
derived using the Friedewald equation (29). Glucose
homeostasis was assessed from glycosylated hemoglobin
(HbA1C) concentration, assayed using boronate afﬁnity
chromatography, a combination of boronate afﬁnity and
liquid chromatography.
Data analysis. We quantiﬁed the cortisol response to stress
by subtracting the values of salivary cortisol concentration
measured immediately after the behavioral tasks from the
baseline. The resulting measure was normally distributed,
and it was transformed for the main analyses into a binomial
variable using a cut point at the value of 4 nmol/l, which
corresponds to the mean value (0.54 nmol/l) þ 1 SD (3.47
nmol/l). hs-cTnT was highly right skewed and was unde-
tectable for 83.3% of the sample (below the lower detection
limit of 3 ng/l); therefore, it was transformed into a binomial
variable (detectable vs. undetectable). Agatston score (CAC)
had a right-skewed distribution and was transformed for
some analyses into a binomial variable by cutting at the value
of zero (0 vs. >0) or 100 (<100 vs. 100). This threshold
was based on the St. Francis Heart Study, which demon-
strated maximum sensitivity and speciﬁcity for detecting
cardiovascular events at a threshold calcium score 100 (30).
We described the study sample according to the expo-
sure (salivary cortisol response to stress tasks) and the
outcome (plasma detectable hs-cTnT) variables. Triglyceride
and CRP levels had right-skewed distributions and were
described using medians and interquartile ranges. Afterward
we used multiple logistic regression to model the association
between cortisol stress response and odds of detectable hs-
cTnT. Cortisol responses may differ according to baseline
cortisol levels and time of testing; therefore, these parameterswere included as covariates. We also adjusted for age, sex,
employment grade, and smoking because they are related to
CVD and may confound the association between cortisol
reactivity and CVD. Additionally, we took into account
clinical variables that are known to be linked to CVD such
as systolic blood pressure, total cholesterol/HDL ratio, and
HbA1c. Moreover, we adjusted for CRP and IL-6 levels to
account for vascular inﬂammation. Finally, we examined
whether the association between cortisol reactivity and hs-
cTnT was independent of underlying coronary atheroscle-
rosis using several approaches: we adjusted for CAC score
as a binomial variable using both cut points separately
(0 and 100), carried out a subanalysis of participants with
no detectable coronary calciﬁcation, and carried out a sub-
analysis of participants with positive CAC scores and in
this case further adjusted for CAC score as a log-linear
variable.
We carried out sensitivity analyses on cortisol responses
by testing several different methods of quantiﬁcation. To
test for dose-response associations, we analyzed the cortisol
response as a continuous variable; we tested a different cutoff
for binomial analysis, deﬁning positive responses as þ0.5 SD
instead of 1 SD; we calculated cortisol responses as the ratio
between the post-stress and baseline values and tested the
resulting variable as a linear variable and in binary analyses
using both þ1 SD and þ0.5 SD as cut points. Additionally,
we checked for an association between the baseline levels of
salivary cortisol and hs-cTnT using multivariate and time-
stratiﬁed (AM/PM) logistic regression models. As for the
multiple adjustments, we further included additional vari-
ables such as physical activity, BMI, alcohol consumption,
and LDL cholesterol, which were not included in the
principal analyses.
Results
A total of 543 participants participated in the study, but 34
(6.3%) had missing information for hs-cTnT and one had
an hs-cTnT value >35 ng/l (limit for AMI diagnosis) and
were therefore excluded. The ﬁnal analytic sample
comprised 508 participants (mean age of 62.9  5.7 years
and 55.1% men). The excluded participants did not differ
signiﬁcantly from the main sample in any covariates. The
sample is described according to cortisol stress response in
Table 1 and according to hs-cTnT categories in Table 2.
The prevalence of detectable hs-cTnT was 16.7%. Older
and male participants were more likely to have detectable hs-
cTnT and higher salivary cortisol responses to stress tasks.
hs-cTnT, cortisol response, and CAC appeared to be
associated with each other: participants with detectable levels
of hs-cTnT were more likely to have higher cortisol
responses and CAC (Table 2), and participants having high
cortisol responses were more likely to have CAC 100
(Table 1). Participants with cortisol responses <4 nmol/l
were more likely to be smokers, and those with detectable
levels of hs-cTnT had higher IL-6 plasma concentrations
Table 1
Characteristics of the Study Sample by Categories of
Cortisol Response to Laboratory Standard Mental
Stress Tasks
Factor and Category
Salivary Cortisol Response
p Value*
<4 nmol/l
(n ¼ 459)
4 nmol/l
(n ¼ 35)
Age, yrs 62.8  5.6 64.7  6.4 0.055
Male 54.5 71.4 0.056
Laboratory session in
the morning
39.2 41.2 0.823
Current smoker 5.5 0.0 <0.001
Latest grade of
employment
0.071
Higher 38.1 51.4
Intermediate 39.4 37.1
Lower 22.4 11.4
Alcohol consumption 0.943
No alcohol 15.5 17.1
Below recommended
levels
71.2 68.6
Above recommended
levels
13.3 14.3
Hours of physical
activity per week
0.727
<1 h 23.3 17.1
1–4 h 32.4 42.9
5–7 h 23.3 14.3
>7 h 21.0 25.7
Body mass index, kg/m2 25.8  3.8 25.8  4.4 0.931
Systolic blood pressure,
mm Hg
128.9  15.6 130.2  15.5 0.628
Diastolic blood pressure,
mm Hg
69.7  8.6 70.6  9.8 0.534
Glycosylated hemoglobin, % 5.4  0.4 5.4  0.4 0.984
Triglycerides, g/l 1.2  0.7 1.1  0.7 0.480y
HDL, mmol/l 1.7  0.5 1.6  0.4 0.527
LDL, mmol/l 3.0  0.9 3.1  0.9 0.628
Total cholesterol, mmol/l 5.3  0.9 5.3  0.9 0.977
C-reactive protein at
baseline, mg/l
1.0  1.4 1.1  1.0 0.780y
IL-6 at baseline, pg/ml 1.3  0.8 1.6  0.9 0.716
Agatston coronary
calcium score
0.037
None 44.7 31.4
<100 32.5 28.6
<400 14.2 25.7
400 8.7 14.3
Agatston coronary calcium
score >100
22.9 40.0 0.025
hs-cTnT detectable (>3 ng/l) 14.8 40.0 <0.001
Values are mean  SD or %. *p values were computed using univariate logistic regression (Wald
test), unless otherwise speciﬁed. Ordered categorical variables such as latest grade of employment,
alcohol consumption, hours of physical activity per week, and Agatston coronary calcium score
were treated as linear. yTwo-sample Wilcoxon rank-sum (Mann-Whitney) test.
HDL ¼ high-density lipoprotein; hs-cTnT ¼ high-sensitivity cardiac troponin T; IL ¼ interleukin;
LDL ¼ low-density lipoprotein.
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hs-cTnT either in bivariate or multivariate models.
Table 3 shows the results of multiple logistic regression
models. We found a robust association between cortisol
response and detectable hs-cTnT (odds ratio [OR]: 3.83;95% conﬁdence interval [CI]: 1.86 to 7.90; p < 0.001).
After adjustment for demographic variables and cardiovas-
cular risk factors, the association between cortisol response
and detectable hs-cTnT did not differ from that in the
unadjusted analysis. After further adjustments for CRP and
IL-6, the association remained (OR: 3.98; 95% CI: 1.60 to
9.92; p ¼ 0.003). The adjustment for CAC score as a binary
variable did not change the effect estimates. In sensitivity
analyses, the results remained unchanged after further
adjustment for physical activity, BMI, alcohol consumption,
and LDL cholesterol (data not shown). We also performed
sensitivity analyses using different approaches to quantify
the cortisol stress response, although the same pattern of
results emerged. For example, after treating the stress res-
ponse as a linear proportional change in cortisol, the fully
adjusted OR for hs-cTnT was 1.38 (95% CI: 1.10 to 1.73;
p ¼ 0.005) for each unit increase in change.
When we restricted the analysis to participants without
detectable coronary calciﬁcation, the evidence of association
remained despite the 40% drop in sample size (n ¼ 222;
OR: 4.77; 95% CI: 1.22 to 18.72; p ¼ 0.025). When the
analysis was restricted to participants with coronary calciﬁ-
cation and adjusted for Agatston CAC score as a log-linear
variable, the association between cortisol stress responses and
cTnT concentration remained (n ¼ 286; OR: 7.39; 95% CI:
2.22 to 24.64; p ¼ 0.001) (Table 3).
Discussion
Our results suggest that in healthy participants with no
history of CVD, a heightened cortisol response to mental
stress is associated with detectable concentrations of circu-
lating cTnT when measured using a high-sensitivity assay.
These ﬁndings add to previous data from our laboratory that
demonstrate an association between cortisol reactivity and
CAC (12,13). However, importantly, although this study
conﬁrms the ﬁndings from other work that stress respon-
sivity is associated with increased CAC (12), the association
between cortisol stress responses and circulating cTnT was
independent of CAC, a reliable indicator of subclinical
coronary atherosclerosis. Therefore, cortisol may be involved
in structural and functional adaptations to the heart as well
as in the atherosclerotic process.
The prevalence of detectable hs-cTnT in our British
sample was 16.7%, which is similar to levels reported
(15.7%) in a nationally representative CVD-free population
sample in the United States (20). To our knowledge, this is
the ﬁrst study to examine the association between mental
stress and cTnT in humans. Our data are consistent with
research on stress-induced Takotsubo cardiomyopathy, in
which emotional stress increases troponin and cortisol levels
in the absence of coronary artery disease (31,32). Our data
also agree with those of Caligiuri et al. (33), who showed
that mental stress in laboratory animals increases troponin
levels. Although stress responses seem to be positively
correlated with troponin, evidence for a direct or indirect
Table 2
Characteristics of the Study Sample by Categories
of hs-cTnT Plasma Concentration
Factor and Category
hs-cTnT
p Value*
Undetectable
(n ¼ 423)
Detectable
(n ¼ 85)
hs-cTnT, ng/l d 5.6  3.9
Age, yrs 62.1  5.1 67.2  6.4 <0.001
Male 51.1 75.3 <0.001
Lab session in the morning 39.8 35.9 0.522
Current smoker 5.4 3.5 0.470
Latest grade of employment 0.190
Higher 40.2 31.8
Intermediate 38.5 43.5
Lower 21.3 24.7
Alcohol consumption 0.201
No alcohol 15.1 20.0
Below recommended
levels
70.9 69.4
Above recommended
levels
14.0 10.6
Hours of physical activity
per week
0.481
<1 h 23.1 22.6
1–4 h 33.0 32.1
5–7 h 23.8 17.9
>7 h 20.2 27.4
Body mass index, kg/m2 25.8  3.9 26.2  3.8 0.436
Systolic blood pressure,
mm Hg
128.5  15.3 131.8  17.4 0.082
Diastolic blood pressure,
mm Hg
69.5  8.5 70.7  9.7 0.262
Glycosylated hemoglobin, % 5.5  0.4 5.5  0.8 0.516
Triglycerides, g/l 1.2  0.8 1.1  0.7 0.059y
HDL, mmol/l 1.7  0.5 1.6  0.4 0.293
LDL, mmol/l 3  0.8 2.9  0.9 0.243
Total cholesterol, mmol/l 5.3  0.9 5.1  1.0 0.024
Salivary cortisol at baseline,
nmol/l
6.5  4.4 7  4.2 0.321
Salivary cortisol response,
nmol/l
0.3  2.9 1.7  5.5 0.004
Salivary cortisol
response 4 nmol/l
5.1 17.1 <0.001
C-reactive protein at
baseline, mg/l
1.0  2.7 1.2  3.2 0.101y
IL-6 at baseline, pg/ml 1.3  0.8 1.6  0.9 0.003
Agatston coronary calcium
score
<0.001
None 47.3 25.9
<100 32.9 28.2
<400 13.2 22.4
400 6.6 23.5
Agatston coronary calcium
score >100
19.9 45.9 <0.001
Values are mean  SD or %. *p values were computed using univariate logistic regression (Wald
test), unless otherwise speciﬁed. Ordered categorical variables such as latest grade of employ-
ment, alcohol consumption, hours of physical activity per week, and Agatston coronary calcium
score were treated as linear. yTwo-sample Wilcoxon rank-sum (Mann-Whitney) test.
Abbreviations as in Table 1.
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1698glucocorticoid modulation of troponin is still scarce. The
troponin gene contains a transcription factor binding site
(34,35), previously shown to bind the activated glucocorti-
coid receptor (36). Despite the presence of this binding site,the effect of glucocorticoids on troponin levels does not seem
to be via direct modulation of gene expression (37–41).
Cortisol has a strong diurnal pattern that can cause difﬁ-
culties in the interpretation of the data; we dealt with this issue
by considering stress response as the difference between the
post-test and pre-test measurements and by adjusting for
cortisol baseline level and day and time of testing at the data
analysis stage. We also performed sensitivity analyses using
different approaches to quantify the cortisol stress response,
although the same pattern of results emerged. It is possible
that the cortisol response to stress contributes to the increased
levels of troponin T observed here by several indirect
mechanisms. First, oxidative stress could play a role in cortisol-
induced troponin release (42,43). Supporting this hypothesis,
the temporal change in serum troponin levels matches the
increase in the concentration of myocardial malondialdehyde,
a marker of free radical lipid peroxidation (44). Second, stress-
induced cortisol levels could increase troponin levels by
modulating ion channels. For example, dexamethasone,
a synthetic glucocorticoid, signiﬁcantly increases the L-type
Ca2þ currents in neonatal rat cardiomyocytes (45) and accel-
erates myocyte spontaneous contractions (46). Finally, cortisol
responses to stress could induce troponin levels by potentiation
of adrenergic signaling. Corticosteroids potentiate adrenergic
signaling and increase muscle contraction and cardiomyocyte
hypertrophy (47). Corticosteroid-potentiated adrenergic signaling
increases mineralocorticoid and glucocorticoid receptor expres-
sion and function in cardiomyocytes (47).
Detectable hs-cTnT is associated with noncardiac
conditions such as severe renal disease (48,49), and theo-
retically, our results could be due to confounding if patients
with renal disease are more likely to test positive on mental
stress tests. However, it is unlikely that this mechanism
underlies our results because the study participants were free
from any chronic conditions at the time of testing, as
explained in the Methods section.
The effect of stress-related cortisol release on cardio-
myocytes may be mediated by atherosclerosis and conse-
quent ischemia, although the adjustments for CAC, which
is a recognized index of atherosclerosis, did not attenuate the
ﬁndings. CAC and hs-cTnT do not appear to lie on the
same causal pathway because their effect was not diminished
by mutual adjustment, despite being correlated with each
other. Thus, cortisol might have acted through indirect
effects as described previously.
Noncalciﬁed coronary plaques are not detectable using
cardiac computed tomography, and that may partly explain
why CAC did not attenuate the association between
cortisol and hs-cTnT. However, there is a direct relation-
ship between the number of calciﬁed plaques present and
total plaque burden, and CAC correlates highly with the
severity of coronary artery disease; therefore, the absence of
calciﬁcation implies that there is probably little signiﬁcant
coronary artery disease (50). On the other hand, it has been
argued that raised troponin T levels may be due to occult or
undetected plaque rupture (51), and it is known that plaque
Table 3
Multiple Logistic Regression Models for the Association Between Salivary Cortisol Response to
Standard Laboratory Mental Stress Tasks (Binary Exposure) and Plasma Detectable hs-cTnT (Binary Outcome)
Model for Detectable hs-cTnT (Outcome)
OR for Cortisol
Response (Exposure) p Value 95% CI
1. Crude association 3.83 <0.001 1.86–7.90
2. Adjusted for baseline salivary cortisol (pre-task) and time of the session (AM or PM) 3.68 0.001 1.75–7.76
3. With further adjustment for age and sex 2.75 0.021 1.16–6.49
4. With further adjustment for latest grade of employment and smoking 2.95 0.014 1.25–7.00
5. With further adjustment for systolic blood pressure, total cholesterol/HDL ratio,
and glycosylated hemoglobin
3.63 0.005 1.49–8.83
6. With further adjustment for CRP and IL-6 3.98 0.003 1.60–9.92
7a. With further adjustment for coronary calciﬁcation score, treated as a binary variable with cutoff at 0 3.98 0.003 1.59–9.95
7b. Same as model 7a but with cutoff set at 100 3.97 0.003 1.59–9.91
7c. Model 6 was restricted to participants without coronary calciﬁcation (CAC score 0, n ¼ 222) 4.77 0.025 1.22–18.72
7d. Model 6 was restricted to participants with coronary calciﬁcation (CAC score >0, n ¼ 286),
for which score it was further adjusted using a log-linear variable
7.39 0.001 2.22–24.64
CAC ¼ coronary artery calciﬁcation; CRP ¼ C-reactive protein; OR ¼ odds ratio; other abbreviations as in Table 1.
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followed by an acute cardiac event (52). This process may
have operated in our patients with minimal CAC score
levels and detectable hs-cTnT.
A single measure of plasma hs-cTnT concentration
cannot be regarded as a robust test if it is not stable in time
(i.e., if it shows remarkable intraindividual short-term vari-
ation). However, the results from the ARIC (Atherosclerosis
Risk in Communities) study showed that hs-cTnT intra-
individual variability over 6 weeks is almost null, with
a correlation coefﬁcient of 0.94 (53). Thus, although our
study collected hs-cTnT after a brief and moderately
stressful behavioral challenge, it is improbable that troponin
T was released in response to this task. To the contrary, we
hypothesized that high cortisol responders are individuals
who are hyperreactive to mental stress in everyday life. If
these responses are elicited on a regular basis over extended
periods of time, they might lead to chronic elevations in
hs-cTnT concentrations.
This was a cross-sectional study, and therefore, we cannot
determine the causal sequence. Heightened cortisol stress
responsivity may contribute to early signs of CVD, or people
at an early stage of cardiac disease may be more prone to
disturbed stress responses. In fact, cardiac troponins are
the most sensitive and speciﬁc biochemical markers of
myocardial damage (54), but their elevation can be due to
a variety of reasons such as pericarditis, myocarditis,
pulmonary embolism, and others (55). However, it is
unlikely that the undetected presence of those conditions
can explain our ﬁndings because no participants reported
any symptoms or signs of cardiac disease; had any previous
diagnosis of or treatment for hypertension, inﬂammatory
disease, or allergies; and did not show any electrocardio-
graphic indications of congenital heart disease on tests
carried out over more than 20 years in the Whitehall II
study. Moreover, we found a strong association in people
with and without coronary calciﬁcation, which is consistent
with another study showing that hs-cTnT is predictive ofCVD in healthy people and of secondary events in patients
with CVD (56). It is interesting to note that detectable
levels of hs-cTnT were associated with salivary cortisol
response to stress test but not with its baseline levels (pre-
test), corroborating its relationship with stress-induced
neuroendocrine dysregulation.
Conclusions
Heightened cortisol responses to mental stress were asso-
ciated with detectable levels of cTnT using high-sensitivity
assays in the plasma of healthy people. Heightened stress-
induced cortisol release may increase the risk of CHD
through several pathways, including atherosclerotic pro-
cesses, or other indirect effects on the cardiomyocytes.
Further research is needed to understand the role of psy-
chosocial stress in the pathophysiology of cardiac cell
damage.
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